American Medical Association

SHERPA: White

People

  1. Giralt
    Giralt
  2. Landau
    Landau
  3. Perales
    Perales
  4. Scordo
    Scordo
  5. Arcila
    Arcila
  6. Caple
    Caple
  7. Concepcion
    Concepcion
  8. Derkach
    Derkach
  9. Dogan
    Dogan
  10. Hassoun
    Hassoun

Groups

  1. Bone Marrow Transplant (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. CTCR Scholars (2)
  6. Epidemiology and Biostatistics (2)
  7. Population Sciences Research Program (2)
  8. Sloan Kettering Institute Postdocs (2)
  9. Survivorship Research (2)
  10. Advanced Practice Providers (1)
Search Within
  1. "Bone Marrow Transplant"
Formats
  1. Journal Article (5)
  2. Guidelines (1)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. CTCR Scholars (2)
  6. Epidemiology and Biostatistics (2)

More Groups

People
  1. Heather Landau (2)
  2. Michael Scordo (2)
  3. Miguel-Angel Perales (2)
  4. Sergio Giralt (2)
  5. Ahmet Dogan (1)
  6. Aisara Chansakul (1)

More People

Years
  1. 2024 (2)
  2. 2021 (3)
  3. 2019 (1)
  4. 2017 (1)
Publications
  1. JAMA Oncology (6)
  2. JAMA - Journal of the American Medical Association (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Graded organ response and progression criteria for kidney immunoglobulin light chain amyloidosis
    Journal Article

    Muchtar, E.; Wisniowski, B.; Geyer, S.; Palladini, G.; Milani, P.; Merlini, G.; SchoĢˆnland, S.; Veelken, K.; Hegenbart, U.; Leung, N.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • T-cell malignant neoplasms after chimeric antigen receptor T-cell therapy
    Research Letter

    Storgard, R.; Rejeski, K.; Perales, M. A.; Goldman, A.; Shouval, R.
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
    Journal Article

    Thompson, M. A.; Henderson, J. P.; Shah, P. K.; Rubinstein, S. M.; Joyner, M. J.; Choueiri, T. K.; Flora, D. B.; Griffiths, E. A.; Gulati, A. P.; Hwang, C.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant
    Journal Article

    Scordo, M.; Wang, T. P.; Ahn, K. W.; Chen, Y.; Ahmed, S.; Awan, F. T.; Beitinjaneh, A.; Chen, A.; Chow, V. A.; Dholaria, B.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation: A consensus project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT
    Guidelines

    Kanate, A. S.; Kumar, A.; Dreger, P.; Dreyling, M.; Le Gouill, S.; Corradini, P.; Bredeson, C.; Fenske, T. S.; Smith, S. M.; Sureda, A.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • FDA approval of tisagenlecleucel: Promise and complexities of a $475 000 cancer drug
    Journal Article

    Bach, P. B.; Giralt, S. A.; Saltz, L. B.
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save